IMA FY 2019 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+1289.2% YoY

Gross Profit

-$11M-81.3% margin

Operating Income

-$18M-134.5% margin

Net Income

-$17M-122.3% margin

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$48M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$86M

Total Liabilities

$147M

Stockholders' Equity

-$61M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$990,000	+1289.2%
Gross Profit	-$11M	-$38M	+70.6%
Operating Income	-$18M	-$41M	+54.8%
Net Income	-$17M	-$41M	+58.8%